Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
, 19 (6), 567-96

Evidence-based Guidelines for the Pharmacological Treatment of Anxiety Disorders: Recommendations From the British Association for Psychopharmacology

Affiliations
Practice Guideline

Evidence-based Guidelines for the Pharmacological Treatment of Anxiety Disorders: Recommendations From the British Association for Psychopharmacology

David S Baldwin et al. J Psychopharmacol.

Abstract

These British Association for Psychopharmacology guidelines cover the range and aims of treatment for anxiety disorders. They are based explicitly on the available evidence and are presented as recommendations to aid clinical decision making in primary and secondary medical care. They may also serve as a source of information for patients and their carers. The recommendations are presented together with a more detailed review of the available evidence. A consensus meeting involving experts in anxiety disorders reviewed the main subject areas and considered the strength of evidence and its clinical implications. The guidelines were constructed after extensive feedback from participants and interested parties. The strength of supporting evidence for recommendations was rated. The guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments.

Similar articles

See all similar articles

Cited by 90 articles

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources

Feedback